Fresenius Medical Care
920 Winter Street
About Fresenius Medical Care
Fresenius Medical Care North America (FMCNA) is proud that our unwavering commitment to our patients has made us the global leader in dialysis healthcare. Our caring professionals touch the lives of over 160,000 patients and their families, combining innovative care with profound personal connections. We're the largest provider of renal care products and services in the nation, including state-of-the-art dialysis machines, dialyzers and pharmaceuticals. We're also home to the country's largest renal specialty laboratories. Every day, our professionals collaborate, challenge one another and ultimately make groundbreaking discoveries that change patients' lives for the better. FMCNA's dialysis care services include hemodialysis, home dialysis and transplant support services, and in-center services to provide our patients with unsurpassed personalized care.
The FMCNA team comprises over 55,000 dedicated employees in North America, all of whom are focused on a singular goal: delivering the highest-quality care to help patients with renal disease live the most fulfilling, rewarding lives possible.
Our facility in Concord CA is our exclusive site for research, development, manufacturing, warehousing and technical services for our durable medical device products including our hemodialysis machine (2008® as well as accessories and upgrade kits) and three peritoneal dialysis systems (Liberty®, Newton IQ® and Freedom Cycler® systems) currently in commercial production. The site is our first and oldest site in North America and was opened in 1986. The site was located in Walnut Creek CA for many years however in 2013 due to the need for significantly more space we relocated to a much larger facility in Concord CA investing in the site’s long-term future. All of the dialysis products used in North America are produced in North America.
Each of the employees working at our Concord plant has a profound commitment to the quality of the products we produce which directly ties into the quality of our patient care. Some faces have been with us since 1986 while others are new as we have grown every year since North American operations began. We are thrilled to have some additional products moving forward through development that will give our patients another treatment option.
113 articles with Fresenius Medical Care
Fresenius Medical Care, the world's largest provider of dialysis products and services, has successfully completed the acquisition of NxStage Medical, Inc., following approval by antitrust authorities in the United States.
Fresenius Medical Care North America Advances Renal Care with Next Generation Dialysis Delivery System Featuring More Than 30 Enhancements
Nearly 100 Percent of Fresenius Kidney Care Facilities Achieve 5-Diamond Patient Safety Status in 2018
Velphoro® Doubles Percentage of Patients Reaching Target Serum Phosphorous Levels in New Study Published in Journal of Renal Nutrition
Fresenius Medical Care North America Examines Impact of Sucroferric Oxydroxide on Hemodialysis Patients with Kidney Failure; High Serum Phosphorous Levels Previously Linked to Increased Cardiovascular Disease
1 in 6 Outpatient Dialysis Patients with Acute Kidney Injury Lasting More Than 90 Days Still Recover Kidney Function, According to New Data from Fresenius Medical Care North America
New Insight from 9,000 AKI Patients Receiving Outpatient Dialysis Treatment; Large Collection of AKI Data is International First and Aims to Spur Further Investigation [24-January-2019] WALTHAM, Mass. , Jan. 24, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading renal care company, announces preliminary results from an analysis o
Agreement brings innovative CytoSorb® therapy to Korea and Mexico and sets the stage for future growth [22-January-2019] MONMOUTH JUNCTION, N.J. , Jan. 22, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and ca
Lower Hospitalization Rates Observed Among Patients New to Hemodialysis with Relative Blood Volume Monitoring Utilizing Crit-Line®
Researchers Discuss Benefits of Fluid Management for Dialysis Patients at the American Society of Nephrology's 2018 Kidney Week Symposium.
Although Hurricane Florence has been downgraded to a Category 2, the massive storm has the potential to dump enough rain to produce catastrophic flooding across the Carolinas. Despite the downgrade, Pfizer is taking no chances and will close its North Carolina injectables plant ahead of the storm.
The medical device market was about $521.2 billion last year and is projected to hit $674.5 billion by 2022. Here’s a look at the top 10 medical device companies in the world this year.
Fresenius Medical Care and Humacyte announce strategic global partnership supported by a $150M equity investment
Fresenius Medical Care and Humacyte, Inc. announced a strategic, global partnership and a $150M USD equity investment.
[30-April-2018] JERUSALEM, April 30, 2018 /PRNewswire/ -- RenalSense(R) has entered into an agreement with Fresenius Medical Care (Bad Homburg) for distribution of its Clarity RMS(R) critical care urine monitoring system in Europe, the Middle East, and Africa (EMEA). Fresenius Medical Care will market the company's products in 85 EMEA countries through its acute care div
Fresenius Medical Care North America, American Nephrology Nurses Association Announce Recipients of Nursing Educational Scholarships
Fresenius Medical Care North America (FMCNA) and the American Nephrology Nurses Association (ANNA) announced five recipients of educational scholarships at ANNA's 2018 National Symposium in Las Vegas.
Modern Healthcare Honors Fresenius Medical Care North America's Saurabh Tripathi with Minority Executives to Watch in Healthcare Award
The profiles of all the winners were featured in the February 26, 2018 print issue of Modern Healthcare
As National Presenting Sponsor of the 2018 Kidney Walks, FMCNA Pledges $750,000 toward Kidney Disease Research and Support
Fresenius Medical Care launched last week in Quanzhou its first independent dialysis center in China.
FMCNA raises largest amount ever by a National Team during the 2017 Kidney Walks for the National Kidney Foundation.
Fresenius Medical Care Achieves Improved Health Outcomes and Savings Through National Medicare Demonstration Program
This success was validated by an independent report from Lewin Group, which showed a nearly nine percent decrease in hospitalization rates for these patients during the same time.
Fresenius Medical Care Showcases Global Research Leadership at World’s Largest Gathering of Kidney Professionals
Fresenius Medical Care announced that company researchers and clinical experts from across the globe will present 77 research abstracts at the 2017 American Society of Nephrology’s (ASN) Kidney Week Symposium.